Several circuits adopted the scope of the patent test: as long as the settlement did not extend the generics exclusion beyond the patents own expiration date, the settlement was presumptively legal under the logic that a patent holder should be able to settle within the scope of the rights the patent grants
performed a cross-trial analysis using data from clinical trials of GLP-1RAs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER-6 [59], and AMPLITUDE-O), SGLT2is (CANVAS and CREDENCE), and finerenone (FIDELIO-DKD and FIGARO-DKD) to estimate the effects of the triple combination therapy of GLP-1RA, SGLT2i, and finerenone using the actuarial method [60]
Photoprotective effects of cannabidiol against ultraviolet-B-induced DNA damage and autophagy in human keratinocyte cells and mouse skin tissue
Monitor for Deficiencies: Rapid weight loss can lead to drops in iron, zinc, and Vitamin D